Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2006 Oct;98(10):1613–1615.

Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients.

Samuel A Giday 1, Zelalem Ashiny 1, Tammy Naab 1, Duane Smoot 1, Alpha Banks 1
PMCID: PMC2569756  PMID: 17052050

Abstract

BACKGROUND: This retrospective study evaluates the degree and distribution of hepatic steatosis in predominantly African-American patients who had liver biopsies over a period of five years in our institution. METHOD: A search in the pathology registry of Howard University Hospital was performed for the presence of fat in liver biopsies. Each biopsy was assessed. RESULTS: Of the 320 liver biopsies that were reviewed, 61 were found to have steatosis. Fifty-six of the 61 patients were African-American. The mean body mass index in those African-American patients was found to be 30. Grade-1 steatosis was found in 16 patients, grade 2 in 22 patients, grade 3 in 14 patients and nine patients had grade-4 steatosis. Four patients fulfilled the criteria for the diagnosis of nonalcoholic fatty liver disease (NAFLD). All four patients had simple steatosis without any inflammation. The frequency of NAFLD in our study population was found to be <2%. Nonalcoholic steatohepatitis was not found in any of our study population. Dyslipidemia was found in all four patients with steatosis. CONCLUSION: NAFLD has a low prevalence in African-American patients. Nonalcoholic steatohepatitis was not found in any of the African-American patients seen at our institution.

Full text

PDF
1613

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angulo Paul. Nonalcoholic fatty liver disease. N Engl J Med. 2002 Apr 18;346(16):1221–1231. doi: 10.1056/NEJMra011775. [DOI] [PubMed] [Google Scholar]
  2. Browning Jeffrey D., Kumar K. Shiva, Saboorian M. Hossein, Thiele Dwain L. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol. 2004 Feb;99(2):292–298. doi: 10.1111/j.1572-0241.2004.04059.x. [DOI] [PubMed] [Google Scholar]
  3. Browning Jeffrey D., Szczepaniak Lidia S., Dobbins Robert, Nuremberg Pamela, Horton Jay D., Cohen Jonathan C., Grundy Scott M., Hobbs Helen H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004 Dec;40(6):1387–1395. doi: 10.1002/hep.20466. [DOI] [PubMed] [Google Scholar]
  4. Brunt E. M., Janney C. G., Di Bisceglie A. M., Neuschwander-Tetri B. A., Bacon B. R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999 Sep;94(9):2467–2474. doi: 10.1111/j.1572-0241.1999.01377.x. [DOI] [PubMed] [Google Scholar]
  5. Caldwell Stephen H., Harris Danielle M., Patrie James T., Hespenheide Elizabeth E. Is NASH underdiagnosed among African Americans? Am J Gastroenterol. 2002 Jun;97(6):1496–1500. doi: 10.1111/j.1572-0241.2002.05795.x. [DOI] [PubMed] [Google Scholar]
  6. Day C. P., James O. F. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998 Apr;114(4):842–845. doi: 10.1016/s0016-5085(98)70599-2. [DOI] [PubMed] [Google Scholar]
  7. Hourigan L. F., Macdonald G. A., Purdie D., Whitehall V. H., Shorthouse C., Clouston A., Powell E. E. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology. 1999 Apr;29(4):1215–1219. doi: 10.1002/hep.510290401. [DOI] [PubMed] [Google Scholar]
  8. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A. J., Natale S., Forlani G., Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001 Aug;50(8):1844–1850. doi: 10.2337/diabetes.50.8.1844. [DOI] [PubMed] [Google Scholar]
  9. Monto Alexander, Alonzo Judy, Watson Jessica J., Grunfeld Carl, Wright Teresa L. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology. 2002 Sep;36(3):729–736. doi: 10.1053/jhep.2002.35064. [DOI] [PubMed] [Google Scholar]
  10. Rubbia-Brandt L., Quadri R., Abid K., Giostra E., Malé P. J., Mentha G., Spahr L., Zarski J. P., Borisch B., Hadengue A. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000 Jul;33(1):106–115. doi: 10.1016/s0168-8278(00)80166-x. [DOI] [PubMed] [Google Scholar]
  11. Sanyal Arun J., American Gastroenterological Association AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002 Nov;123(5):1705–1725. doi: 10.1053/gast.2002.36572. [DOI] [PubMed] [Google Scholar]
  12. Seidell J. C. Obesity, insulin resistance and diabetes--a worldwide epidemic. Br J Nutr. 2000 Mar;83 (Suppl 1):S5–S8. doi: 10.1017/s000711450000088x. [DOI] [PubMed] [Google Scholar]
  13. Selzner M., Clavien P. A. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21(1):105–113. doi: 10.1055/s-2001-12933. [DOI] [PubMed] [Google Scholar]
  14. Teli M. R., James O. F., Burt A. D., Bennett M. K., Day C. P. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995 Dec;22(6):1714–1719. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES